of life, approximately 10% will continue to have stature below the 3rd centile throughout childhood and adolescence and into adulthood [1] . To date, however, the mechanisms linking intrauterine growth retardation (IUGR) to postnatal short stature are still unknown [2] . It is known that birth length is an important predictor of fi nal height [3] [4] [5] . Consistent with this, we have recently found a close correlation between birth length and catchup growth expressed as height corrected for target height ( fi g. 1 ). However, the endocrine mechanisms linking preand postnatal growth remain undetermined.
alteration in the GH-IGF axis is transient, however, and normalization of GH, IGF-I and IGFBP-3 secretion occurs in early postnatal life [8] .
Most short children born SGA show normal GH responses to stimulation tests and normal serum levels of IGF-I and IGFBP-3 [9] . A number of studies have focussed on spontaneous daily GH secretion in these individuals. Ackland et al. [10] found alterations in spontaneous GH secretion that were subsequently confi rmed by de Waal et al. [11] and Boguszewski et al. [12] . The observed alterations consist of a high pulse frequency, attenuated pulse amplitude and relatively elevated interpulse concentrations of serum GH. In the study of de Waal et al. [11] , nearly 60% of children born SGA showed an abnormal physiological daily secretion of GH, characterized by decreased pulse amplitude. This altered pattern of spontaneous GH release was associated with reduced concentrations of IGF-I. Thieriot-Prevost et al. [13] reported that children born SGA with poor length gain during the fi rst 12 months of life (length SD score ! -2 at 1 year) had low levels of IGF-I. Together, these fi ndings suggest that at least some children born SGA may have reduced or altered physiological GH secretion. These alterations are similar to those documented in adults with prolonged critical illness [14] . The abnormal pattern of GH secretion in children born SGA could therefore represent a neuroendocrine consequence of prolonged critical illness before birth [15] . Nevertheless, it should be noted that the assessment of spontaneous GH secretion is burdened by wide inter-and intra-individual variability, and that, although IGF-I and IGFBP-3 levels tend to be in the low-normal range in children born SGA, they are much higher than those observed in children with GH defi ciency.
The IGF System
IGF-I and IGF-II are major regulators of pre-and postnatal growth. They circulate bound to high-affi nity IGFbinding proteins (IGFBP-1 to IGFBP-6) that modulate IGF bioavailability [16] . Approximately 75% of circulating IGFs are bound in a ternary complex, consisting of IGF, IGFBP-3 and an acid-labile subunit.
Reduced circulating IGF-I levels have been reported in fetuses that are SGA and neonates born SGA, suggesting a role for IGF-I in fetal growth retardation [8, 17] . More direct evidence for a role of IGF-I in fetal and postnatal growth comes from gene deletion studies in mice. Weight and length at birth were signifi cantly reduced in IGF-I knockout mice, and postnatally they showed a further deterioration of growth [18, 19] . In humans, homozygous partial deletion of the gene encoding IGF-I is associated with severe impairment of pre-and postnatal growth [20] . An association has been reported between IGF-I polymorphisms and pre-and postnatal growth retardation [21, 22] .
The importance of the intrauterine growth-promoting action of IGF-I has also been confi rmed by the fi nding of severe IUGR and postnatal growth failure in two children with mutations in the IGF-I receptor gene [23] . In addition, infants born SGA have reduced IGFBP-3 concentrations and increased IGFBP-1 and IGFBP-2 levels [17] .
Despite evidence for abnormalities in IGF levels in infants born SGA, no relationship has been found between the IGF-related variables at birth and postnatal growth [2, 8] . In a recent cross-sectional study, we have found a correlation between the IGF-I/IGFBP-3 molar ratio in childhood and catch-up growth, expressed as actual height corrected for target height ( fi g. 2 ). The affi nity of IGFBPs for IGFs may be reduced by the intervention of specifi c cation-dependent proteolytic enzymes (IGFBP proteases) that, by fragmenting IGFBPs, lead to an increased free IGF-I fraction and, ultimately, augmented IGF-I bioavailability. We reported the presence of two different proteases in children born SGA. One is present at birth and yields the 29-kDa form of IGFPB-3 as the major proteolytic fragment, and the second one, active at 2 months of age, produces an 18-kDa IGFBP-3 fragment [8] . The intervention of the second protease may result in increased IGF-I availability in tissues, which could lead to the postnatal catch-up growth that occurs in the fi rst 6-12 months of life. Consistent with this, we found that the relative amount of the IGFBP-3 18-kDa fragment correlated with early postnatal growth [24] . Taken together, these fi ndings suggest that the growthpromoting machinery is 'frozen' in fetuses that are SGA, probably to minimize the energy expenditure for growth and to favour the development of vital organs. During the fi rst weeks of postnatal life, the IGF system becomes active, which allows catch-up growth in the vast majority of children born SGA.
The reported alterations in the IGF system in individuals born SGA have been observed during early postnatal life. A case-control study of older children who were born SGA did not show any signifi cant alteration of IGF-I and IGFBP-3 levels [25] . Even after subdividing the children according to whether or not they achieved catch-up growth, we found no signifi cant differences between the groups in the concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-3, soluble IGF-II receptor, and the relative amounts of circulating forms of IGFBP-3 produced by proteolysis [24, 25] . This indicates that the alterations in IGF-I levels observed in neonates born SGA are transient.
The Hypothalamic-Pituitary-Adrenal Axis
The function of the hypothalamic-pituitary-adrenal axis can be permanently programmed during development [26] . In animals, exposure to glucocorticoids in prenatal and early postnatal life may imprint the hypothalamic-pituitary-adrenal axis, resulting in permanent modifi cation of the neuroendocrine response to stress throughout life [27] .
We have reported that catch-up growth in children born SGA might be affected by intrauterine programming of the hypothalamic-pituitary-adrenal axis. Preliminary results of a case-control study in 40 children born SGA (20 who achieved catch-up growth and 20 who did not), matched for sex, age (within 1 year), pubertal status and body mass index (within 0.5 kg/m 2 ), show that children who did not achieve catch-up growth have significantly higher fasting plasma cortisol levels than children who did achieve catch-up growth ( fi g. 3 ). Furthermore, during the neonatal period, cortisol may act by limiting IGFBP-3 proteolysis, thus reducing IGF bioavailability and ultimately leading to early growth impairment [24] .
Thyroid Function
Reductions in circulating concentrations of free thyroxine and free tri-iodothyronine and a modest elevation in concentrations of thyrotrophin (TSH) have been reported in fetuses with IUGR [28] . A signifi cant reduction in the expression of isoforms of the thyroid receptor in the human fetal nervous system during IUGR has also been described [29] . We previously reported that children born SGA who do not show postnatal catch-up growth have higher, though normal, TSH concentrations than individuals born SGA who do achieve catch-up growth [25] . Recently, abnormal thyroid function has been found in children born SGA when compared with children born at a weight appropriate for gestational age [30] . Amazingly, up to 20% of the children born SGA showed TSH serum levels above the upper limit of normality. However, it has to be pointed out that most of the children born SGA studied by Radetti and co-workers were born preterm. In our recent case-control study, we did not fi nd any signifi cant difference in thyroid function between children born SGA at term with or without postnatal catch-up growth ( fi g. 3 ).
Conclusion
IGF-I is a major determinant of prenatal and early postnatal growth, as demonstrated in animal models and humans born with genetic abnormalities of the IGF system. Neonates born SGA show transient alterations of the GH-IGF-I axis and IGF system, probably refl ecting the in utero endocrine pattern. In infancy and childhood, IGF-I and IGFBP-3 concentrations are in the low-normal range and GH responses to stimulation tests are normal, although subtle alterations of spontaneous GH secretion have been described.
There is evidence suggesting that the hypothalamicpituitary-adrenal axis and thyroid function may regulate pre-and postnatal growth in children born SGA, at least in early life. However, data are still confl icting, probably due to the different assessment methods used and the different populations studied.
Whilst no endocrine parameter seems to be a reliable predictor of the linear growth outcome, the major predictors of height in children born SGA are birth length, target height and body mass index.
